From a clinical perspective, this result is concordant with the increased expression of PPARδ in invasive breast cancer [12, 32] and by manifestation of a PPARδ signaling network that predicts poor survival in this disease [33]. The gene discussed is PPARD; the disease is invasive breast carcinoma.